Several drugs have been associated with an increased risk of erectile dysfunction (ED). We analysed the role of pharmacological treatments on the risk of ED using data from a cross-sectional study on prevalence and risk factors for ED in the general population in Italy. A total of 2450 men aged more than 18 years were randomly identified by 143 general practioners (GP) among their registered patients and invited to a confidential interview by their GP. Patients were asked 'about their ability to achieve and maintain an erection sufficient for satisfactory sexual performance'. If they were dissatisfied, they were defined as having ED. Out of the 2450 men identified, 440 (18%) refused to participate. The present analysis therefore includes information on 2010 men. After adjustment for related pathologies, anxiolytics and antidepressants showed insignificantly higher odds ratio (ORs, respectively, 1.7 and 2.1); antipsychotic drug use significantly increased the risk of ED (OR 9.0, 95% confidence interval, CI 1.8-44.4). Diuretics (OR 3.1, 95% CI 1.4-6.9) and anticholinergic drugs (OR 12.8, 95% CI 2.7-60.1) were associated with ED risk. No association emerged between ED and H2 antagonists, anticholesterolemic or hypoglycemic drugs. In conclusion, after taking account of related pathologies, our results suggest that men treated with antipsychotic, diuretic and anticholinergic drugs are at greater risk of ED.
Introduction
Erectile dysfunction (ED) is the consistent inability to attain and maintain a penile erection sufficient for satisfactory sexual performance.
1 Some epidemiological observations have shown an association between ED and several pathological conditions, such as cardiovascular diseases, diabetes and urological diseases including pelvic traumas.
2,3 ED may be related to age, 3,4 smoking 2,5 and physical activity. 6 Several drugs have been associated with an increased risk of ED, 7, 8 such as antihypertensive agents 9 and antidepressants, 10, 11 but data on the issue are scanty.
We conducted a cross-sectional study on the prevalence and risk factors for ED in the general population in Italy. 12 In this report, we focus on the relation between drugs and ED risk.
Materials and methods
Men aged more than 18 years were identified by 143 general practioners (GP) in the three main areas of Italy (North, Center, South), among their registered patients during the period January 1996 to February 1997, using a computer-generated random numbers list. A total of 2450 men were identified and invited to a confidential interview with the GP. Using a standard questionnaire, data were obtained about their age, education, marital status, cigarette smoking, weekly alcohol consumption, medical history, current use of medications and age at first intercourse. When useful, information given by the patient was checked with the medical records. In particular, any chronic conditions (cardiovascular disease, hypertension, coronary heart disease, diabetes, nephropathy, pelvic surgery or radiation), regardless of their severity, were reported in the questionnaire after checking the information in the clinical records. Information on current use of selected classes of drugs was recorded (anxiolytics, antidepressants, anticholinergics, antitumorals, cardiovascular agents, antihypertensives, oral antidiabetics, anticholesterolemics, H2 antagonists, hormones, antipsychotics, urological agents). These classes of drugs were selected since the study was planned, they were suspected to be correlated with ED risk. At the end of the interview, subjects were asked 'about their ability to achieve and maintain an erection sufficient for satisfactory sexual performance'. If they answered they were dissatisfied, they were considered as having ED.
Out of 2450 men identified, 440 (18%) refused to participate (334 for 'personal' reasons, and 106 on account of a clinical condition). The present analysis therefore includes information on 2010 men. The average number of interviews for each GP was 14 (range 3-33). Each subject gave informed consent before interview. The study protocol did not include any clinical or diagnostic procedures.
Odds ratios (ORs) as estimators of the relative risk of ED and the corresponding 95% confidence intervals (CIs) were computed using unconditional multiple logistic regression.
The odds of an event were the ratio of the number of events to the number of nonevents. An event was defined by the presence of an exposure to a suspected causal agent or risk factor. The odds of exposure of cases were divided by the odds of exposure among controls to derive the OR. The association between exposure and outcome was expressed as the OR. The OR was interpreted as follows: an OR of 1 implied no association. If the OR was greater than 1, and its 95% CI did not include 1, then the result implied a positive association between exposure and outcome at the 5% significance level (ie, the odds of exposure was greater in cases than in controls). If the OR was less than 1, and its 95% CI did not include 1, then the result implied a negative association between exposure and outcome at the 5% significance level (ie, the odds of exposure was smaller in cases than in controls). If the 95% CI included the OR of 1, then an association of exposure and outcome was not proved by the study at the 5% significance level. The closer the OR was to the value of 1, the more the clinical significance of the association was limited, even if the OR was statistically significant. We included as terms in the logistic regression equation the pathologies related to the use of each class of drug (for example, anxiety and depression for anxiolytics and antidepressants). The terms included are indicated in the footnotes to the tables.
Results
Among 2010 interviewed men, 257 fulfilled the definition of ED and were classified as cases; 1753 were controls. Table 1 shows the distribution of men with and without ED according to age and selected factors and medical history. The frequency of ED increased with age and decreased with increasing years of education; a significant association emerged with smoking. Significant increases of OR emerged for medical history of hypertension, diabetes, neuropathy, pelvic injury and surgery, anxiety and/or depression and gastric ulcer. Hypercholesterolemia did not affect the risk of ED.
The relation between ED and several drugs was considered in Table 2 . After adjustment for the related pathologies, anxiolytics and antidepressants showed insignificantly increased OR (respectively 1.7 and 2.1); antipsychotic drugs use significantly 
Discussion
Potential limitations of this study must be considered. First of all, the study population were men randomly identified in the lists of a network of GPs. The GPs, however, were not randomly identified among all Italian GPs, so their patients cannot be considered representative of the Italian population. Nevertheless, GPs participating in this study were well distributed over the main areas of the country and there were no marked differences in the estimated prevalence of ED among their patients (data not shown), giving strong support to the consistency of the general results. Finally, participation in the study was high (more than 80%).
The strengths of the study included the fact that it provides the opportunity of analysing the role of several pharmacological treatments on ED risk in a large series of men. Further, the patients were interviewed by their GPs, so the information about medical history should be accurate. Another important limitation of this analysis is that we did not collect information on specific drugs; thus, we can analyse the effect of selected classes of drugs, but not of each drug, on ED risk.
As sexual dysfunction is a common feature of several illnesses, such as hypertension, cardiopathy, diabetes and depression, so it is difficult to assess the contribution of disease and drug therapy. In some cases, drugs affecting sexual function could improve the pathology that caused impotence, masking their own adverse effect. Moreover, among men with severe illness, we usually do not find an 'untreated' group of patients for the comparison.
Many drugs have been reported to cause ED. We found a significant association between ED risk and current use of anticholinergics, diuretics and antipsychotics. The relation with anxiolytics and antidepressants was not statistically significant, possibly because few men had concomitant ED and depression or anxiety. The independent role of the drugs seemed to be confirmed by performing analyses in strata of the presence/absence of related pathologies.
In etiopathogenic terms, the relation between antipsychotic or antidepressant drugs and ED may be because of the interference with central neurotransmitter pathways subserving potency. Monoamine oxidase inhibitors and tricyclic antidepressants were commonly complicated by ED, and benzodiazepines and selective serotonine reuptake inhibitors have been reported to cause erectile failure and decreased libido. Current drug use and risk of ED E Ricci et al ED complicated the treatment with several diuretic drugs; the mechanism of this side effect is unknown for thiazide diuretics, but those agents may have a direct effect on vascular smooth muscle or reduce the response to catecholamines; it is recognised that spironolactone can cause erectile failure as well as gynecomastia and a decrease in libido, acting as an antiandrogen at the target tissue.
14 However, we did not collect information on specific drugs, but only on drug classes.
Cimetidine, a histamine H2-receptor antagonist, has been reported to blunt libido and cause erectile failure, acting as an antiandrogen and causing hyperprolactinemia. This may be because of its effect on the hypothalamic-hypophyseal-gonadal axis, 15 although data on the association between H2-receptor antagonist and ED risk are controversial. For example, two studies comparing cimetidine and ranitidine in terms of efficacy and side effects 16, 17 found that men treated with cimetidine experienced impotence (reversible after withdrawing the drug), whereas men taking ranitidine had no increase in the frequency of ED. The present study found no increase in the risk of ED for any H2 antagonists users in comparison with nonusers.
In conclusion, after taking account of related pathologies, our results suggest that men treated with antipsychotic, diuretic and anticholinergic drugs are at greater risk of ED.
